Entac Ampoule Special Precautions

Symptomatic response to therapy with Ranitidine Injection does not preclude the presence of gastric malignancy.
Ranitidine is excreted primarily by the kidney dosage should be adjusted in patients with impaired renal function.
Observed patients with hepatic dysfunction since Ranitidine is metabolized in the Liver.
Bradycardia in association with rapid administration of ranitidine Injection has been reported rarely, usually in patients with factors predisposing to cardiac rhythm disturbances. Recommended rates of administration should not be exceeded.
Rare reports suggest that ranitidine may precipitate acute porphyric attacks in patients with acute porphyria. Ranitidine should therefore be avoided in patients with a history of acute porphyria.